News Alexion signs R&D deals with two Nordic biotechs Alexion has signed a deal with two Nordic biotechs to bolster its pipeline of potential rare disease drugs.
News Lilly sues over 'illegal sales' of obesity drug retatrutide Eli Lilly has sued six US-based companies it accuses of participating in an illegal black market for experimental weight-loss drug retatrutide.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
